The purpose of the CamNTF is to promote interactions between scientists from academia & industry in order to improve opportunities for biotechnology research and development. Meeting attendance is free but all attendees must register in advance.

Host: Astex Pharmaceuticals

Programme
18:00 – Welcome: Dr Marc O’Reilly, Vice President, Molecular Sciences, Astex
Pharmaceuticals
Session Chair: Dr Elena Di Daniel, Senior Director, CNS, Astex Pharmaceuticals
18:05 – Dr Clare Jones , Chief Scientific Officer, Talisman Therapeutics
Talk title: Use of human stem cell models of neurodegeneration to advance drug discovery
18:30 – Dr Donna Finch, Head Of Translational and Clinical Science, Alchemab Therapeutics
Talk title: Finding novel targets in Neurodegeneration via Antibody Repertoire analysis of
resilient patients
18:55 – Dr James McCarthy, Senior Research Associate, Astex Pharmaceuticals
Talk title: Role of SQSTM1 (P62) in mitochondrial function and clearance in iPSC Neurons
19:10 – Post-talk speaker session chaired by Dr Greg O’Sullivan, External Science &
Innovation, CNS, Astex Pharmaceuticals
19:40 – Meeting close